Reneo Pharmaceuticals, Inc. (RPHM) Social Stream
RENEO PHARMACEUTICALS INC (RPHM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering RENEO PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $45 | $24 | $31.333 | $1.69 | 1754.02% |
| 2021-11-22 | 4 | $45 | $24 | $34.75 | $1.69 | 1956.21% |
| 2022-01-05 | 5 | $45 | $24 | $33.4 | $1.69 | 1876.33% |
| 2022-01-27 | 6 | $45 | $24 | $32.5 | $1.69 | 1823.08% |
| 2022-03-23 | 6 | $45 | $15 | $30.833 | $1.69 | 1724.44% |
| 2022-03-25 | 5 | $45 | $15 | $30.333 | $1.69 | 1694.85% |
| 2022-05-10 | 6 | $45 | $15 | $30.333 | $1.69 | 1694.85% |
| 2022-05-12 | 6 | $45 | $15 | $29.666 | $1.69 | 1655.38% |
| 2022-05-17 | 6 | $42 | $15 | $25.166 | $1.69 | 1389.11% |
| 2022-11-08 | 6 | $42 | $15 | $26.833 | $1.69 | 1487.75% |
| 2022-11-09 | 6 | $42 | $15 | $26.333 | $1.69 | 1458.17% |
| 2023-05-14 | 6 | $42 | $15 | $26 | $1.69 | 1438.46% |
| 2023-07-03 | 6 | $42 | $15 | $25.5 | $1.69 | 1408.88% |
| 2023-08-11 | 6 | $42 | $15 | $24.4 | $1.69 | 1343.79% |
| 2023-11-14 | 6 | $42 | $15 | $25.333 | $1.69 | 1398.99% |
| 2023-11-15 | 8 | $42 | $15 | $26.943 | $1.69 | 1494.26% |
| 2023-12-14 | 8 | $42 | $1.4 | $24.243 | $1.69 | 1334.5% |
| 2023-12-15 | 8 | $35.55 | $1 | $6.892 | $1.69 | 307.81% |
The Trend in the Analyst Price Target
RPHM's average price target has moved down $15.55 over the prior 15 months.
RPHM reports an average of 397.27% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 6 | 42.00 | 15 | 26.000 | 2.68 | 870.15% |
| 2023-02-16 | 5 | 42.00 | 15 | 26.000 | 2.91 | 793.47% |
| 2023-07-03 | 6 | 42.00 | 15 | 25.500 | 6.41 | 297.82% |
| 2023-11-14 | 6 | 42.00 | 15 | 25.333 | 6.34 | 299.57% |
| 2023-12-15 | 8 | 35.55 | 1 | 6.892 | 1.42 | 385.35% |
RPHM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.13 | 0 | 0 | 7 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
RPHM's average broker recommendation rating worsened by 2.12 over the prior 153 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how RENEO PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2502.49% of that group.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, RENEO PHARMACEUTICALS INC's number of analysts covering the stock is greater than 2388.33% of them.
- RENEO PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2166.42% of stocks in the micro market cap category.
- RENEO PHARMACEUTICALS INC's average analyst price target is higher than 2143.68% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RENEO PHARMACEUTICALS INC are ANEB, ACXP, and RNXT.
View All Top Stocks by Price Target
What is the outlook for RPHM? Use POWR Ratings for clearer insight into price direction.